Sun Pharma is terming out the Organon bridge, ₹10,000 crore across two rupee tranches with coupons of 8.20% and 8.05%. The bigger ₹7,000 crore piece matures 2031; the ₹3,000 crore tranche carries a 20

What happened: Sun Pharmaceutical Industries plans to raise ₹10,000 crore through two tranches of rupee-denominated bonds to refinance bridge loans for its Organon acquisition. Key numbers: ₹10,000 crore total; first tranche ₹7,000 crore at 8.20% coupon; Organon acquisition valued at $11.75 billion. Why it matters: The bond sale refinances bridge loans taken for the $11.75 billion Organon deal, with institutional investors including SBI Pension Fund and ICICI Prudential Mutual Fund expected to participate.

Sun Pharmaceutical Industries plans to raise ₹10,000 crore through two tranches of rupee-denominated bonds to refinance bridge loans for its Organon acquisition.

The bond sale refinances bridge loans taken for the $11.75 billion Organon deal, with institutional investors including SBI Pension Fund and ICICI Prudential Mutual Fund expected to participate.